- Koji Fujita, Assistant Professor, Department of Orthopaedic and Spinal Surgery, Graduate School of Medical and Dental Science at Tokyo Medical and Dental University
- Atushi Hashizume, Clinical Fellow, Department of Neurology, Graduate School of Medicine at Nagoya University
- Ryuji Kato, Associate Professor, Department of Basic Medical Science, Laboratory of Cell and Molecular Bioengineering, Nagoya University Graduate School of Pharmaceutical Sciences
- Sumimasa Nagai, Senior Assistant Professor, Division of Genetic Therapeutics, Advanced Clinical Research Center, the Institute of Medical Science, University of Tokyo (IMSUT) & Department of Hematology/Oncology and Center for Translational Research, IMSUT Hospital.
- Haruka Nakada, Project Research Fellow, Department of Public Policy, Human Genome Center, the Institute of Medical Science, University of Tokyo
- Yukika Nishimura, Deputy Manager, Department of Clinical Research and Trials, Japan Agency for Medical Research and Development (AMED)
- Takeshi Ohama, Associate Professor, Department of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University
- Wataru Shibata, Associate Professor at the Advanced Medical Research Center, Yokohama City University
- Yukata Shimazu, Project Researcher, Department of Immunology, Institute for Frontier Medical Services, Kyoto University
- Tomohiro Yamaguchi, Medical Reviewer, Office of New Drug V at the Pharmaceuticals and Medical Devices Agency (PMDA)
Koji Fujita is an Assistant Professor at the Graduate School of Medical and Dental Science, Department of Orthopaedic and Spinal Surgery, Tokyo Medical and Dental University. His area of expertise is osteoporosis and he conducts basic research for developing new drugs and clinical research for fall prevention as well as surgery of the upper extremity. Dr. Fujita holds an MD and PhD in Orthopedics from Tokyo Medical and Dental University. In addition to professional working experiences at several different institutions in Japan, Dr. Fujita was a Research Fellow at the Mayo Clinic in Rochester, Minnesota for two and a half years and worked on research in bone biology and osteoporosis.
Atushi Hashizume is a Clinical Fellow at the Department of Neurology at the Graduate School of Medicine, Nagoya University. Dr. Hashizume’s expertise is in neurology and he conducted investigator-initiated clinical trials on anti-androgen therapy for spinal and bulbar muscular atrophy (SBMA). Dr. Hashizume also serves as an Expert Advisor for the Pharmaceutical and Medical Devices Agency (PMDA) and evaluates the quality, efficacy and safety of drugs in the area of cerebral infarction, Parkinson’s disease, Alzheimer’s disease and other neurological disorders. Dr. Hashizume holds an MD and PhD from Nagoya University School of Medicine, and a Bachelor of Health Science from the University of Tokyo.
Ryuji Kato is an Associate Professor at the Department of Basic Medical Science, Laboratory of Cell and Molecular Bioengineering, Nagoya University Graduate School of Pharmaceutical Sciences. Dr. Kato’s expertise includes cell culture engineering, bioinformatics, and protein engineering. His current research focuses on medical engineering for regenerative medicine and drug development. As a principal lead researcher, his responsibilities include developing novel technologies in the field of cell therapy and regenerative medicine as well as teaching students in the field of regenerative medicine. Dr. Kato also serves as a committee member of an ISO technical committee (TC276: Biotechnology) in Japan. Dr. Kato holds a PhD in Engineering from Nagoya University, a Master of Bioscience from Nara Institute of Science and Technology, and bachelor’s degree in chemistry and biology from Tohoku University.
Sumimasa Nagai is a Senior Assistant Professor at the Division of Genetic Therapeutics, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo (IMSUT) and at the Department of Hematology/Oncology and Center for Translational Research, IMSUT Hospital. At the IMSUT, Dr. Nagai prepares registration trials for chimeric antigen receptor T-cell therapy and is responsible for outpatient care as well as supporting translational research, clinical studies and investigator-initiated registration trials. In addition, Dr. Nagai serves as a clinical advisor at the Office of New Drug V (Oncology) and the Companion Diagnostics Working Group, PMDA, where he assists in regulating oncologic drugs and companion diagnostics. Dr. Nagai holds an MD and PhD from the University of Tokyo.
Haruka Nakada is a Project Research Fellow at the Department of Public Policy, Human Genome Center, the Institute of Medical Science, the University of Tokyo. Dr. Nakada’s expertise is in the interdisciplinary area of healthcare and law, where her interest is to explore ways to solve the potential social issues associated with innovation in medical technologies. Dr. Nakada conducts studies on ethical, legal, and social issues related to medical research. Her research topic discusses ethical issues related to research and development regarding implanted medical devices and the ethical issues related to clinical trials from the perspective of patients. Dr. Nakada holds a PhD in Integrated Science from the Graduate School of Frontier Science, the University of Tokyo, a JD from the Waseda University Law School, and a BS in Health Science and Nursing from the University of Tokyo.
Yukika Nishimura serves as the Deputy Manager at the Department of Clinical Research and Trials, Japan Agency for Medical Research and Development (AMED), where her office supports Translational and Clinical Research Core Centers projects and allocates funds for research and trials. Prior to joining AMED, Dr. Nishimura was a Project Research Associate at the School of Medicine, the University of Tokyo and worked on exploratory research using functional brain imaging aimed at psychiatric diagnosis based on biological markers. Dr. Nishimura is currently in charge of the early-phase/exploratory phase of international-standard clinical research. In this role she provides feedback about the appropriate use of research funding and acts as a mediator between researchers and program supervisors. She also takes part in conducting symposia that promote translation from basic research to clinical application. Dr. Nishimura holds a PhD and MMS from the Graduate School of Medicine, Mie University and a BA from Keio University.
Takeshi Ohama is an Associate Professor at the Department of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University. Dr. Ohama conducts research on the development of a novel anti-cancer strategy targeting protein phosphates and teaches veterinary pharmacology for third and fourth year students.. He worked as a Research Associate at the Center for Cell Signaling at the University of Virginia, where he conducted experiments to clarify the role of protein phosphates in cell signaling. Dr. Ohama holds a PhD in Veterinary Medicine and DVM from the University of Tokyo.
Wataru Shibata is an Associate Professor at the Advanced Medical Research Center, Yokohama City University. Dr. Shibata specializes in gastroenterology and his responsibilities include managing the biobank, coordinating translational research, conducting clinical work and doing interviews with clinicians to find out if there are any unmet scientific needs to be resolved at bedside. In addition, Dr. Shibata conducts his own research for gastrointestinal cancer by using mice cancer models and clinical samples to develop cures for those diseases. Dr. Shibata worked at Columbia University Medical Center as a postdoctoral research scientist. He holds a PhD in Gastroenterology from the University of Tokyo and an MD from Yamagata University.
Yutaka Shimazu is a Project Researcher at the Department of Immunology, Institute for Frontier Medical Sciences, Kyoto University. Dr. Shimazu’s specialty is in the field of cancer immunology and iPS technology and he conducts basic research on cancer immunology to apply new technology in clinical practice and to regenerate cancer antigen specific cytotoxic T cells (CTLs) by utilizing iPS technology. Collaborating with the Department of Hematology and Oncology of Kyoto University, Dr. Shimazu’s team has applied their methods in clinical practice. Previously, he has worked at various institutions including the Department of Hematology at Kurashiki Central Hospital, Department of Hematology/Oncology at Kyoto University, and the Immunology Frontier Research Center at Osaka University. Dr. Shimazu holds an MD from Kyoto University.
Tomohiro Yamaguchi serves as a Medical Reviewer at the Office of New Drug V at the Pharmaceuticals and Medical Devices Agency (PMDA). As a medical reviewer with extensive background in medical oncology and associated clinical trials, Dr. Yamaguchi is involved in the regulatory review and approval process for various oncology products in Japan and provides regulatory advice in clinical trial consultations for pharmaceutical companies and academic institutions. Prior to joining PMDA, he worked at the National Cancer Center Hospital, where he was involved in clinical trials, and at the Japan Clinical Oncology Group (JCOG) Data Center, where he served as a Chief Resident Fellow supporting clinical trials on cancer. Dr. Yamaguchi holds a PhD in Biostatistics from Yokohama City University and an MD from Tohoku University.
Mansfield-PhRMA Research Scholars 2015
- Hisayoshi Hashimoto, Research Resident, Division of Molecular and Cellular Medicine, National Cancer Center Research Institute
- Yoichi M. Ito, Associate Professor, Department of Biostatistics, Hokkaido University Graduate School of Medicine
- Hiroya Kuwahara, Research Assistant Professor, Department of Neurology and Neurological Science, Tokyo Medical and Dental University
- Kazue Mizuno, Research Fellow of Japan Society for the Promotion of Science, Department of Materials and Science, The University of Tokyo, School of Engineering
- Fumihiko Nakatani, Head, Musculoskeletal Oncology, National Cancer Center Hospital
- Takayoshi Shimohata, Associate Professor, Department of Neurology, Niigata University, Brain Institute
- Keiko Ueda, Chief Researcher, Department of Regenerative Medicine, National Cardiovascular Center
- Kiyoshi Yamaguchi, Assistant Professor, Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo
Mansfield-PhRMA Research Scholars 2014
- Kazuki Hattori – Project Assistant Professor, The University of Tokyo
- Akihiro Hirakawa – Lecturer, Nagoya University Hospital
- Mako Kamiya – Assistant Professor, The University of Tokyo
- Ken Kato – Chief/Head, National Cancer Center Hospital
- Masahisa Katsuno – Associate Professor, Nagoya University Graduate School of Medicine
- Makiko Kusama – Lecturer, The University of Tokyo
- Akiko Nitta – Reviewer, Pharmaceuticals and Medical Devices Agency (PMDA)
- Kiyoshi Okada – Project Associate Professor, Okada University Hospital
- Koichiro Yuji – Project Lecturer, The University of Tokyo
Mansfield-PhRMA Research Scholars 2013
- Yasushi Goto – Assistant Professor, The University of Tokyo Hospital
- Taizo Hirata – Associate Professor, Okayama University Hospital
- Yukako Imanaka – Officer, National Institute of Biomedical Innovation (NIBIO)
- Toru Komatsu – Assistant Professor, The University of Tokyo
- Kuniyasu Niizuma – Clinical Associate Professor, Tohoku University Graduate School of Medicine
- Toru Oga – Associate Professor, Graduate School of Medicine, Kyoto University
- Daisuke Sugiyama – Unit Leader/ Associate Professor, Center for Clinical and Translational Research of Kyushu University Hospital
- Kanako Takatsuki – Reviewer, Pharmaceuticals and Medical Devices Agency (PMDA)
- Issei Takayama – Technical Officer, Pharmaceuticals and Medical Devices Agency (PMDA)
- Kan Yonemori – Medical Staff, National Cancer Center Hospital, Tokyo